Susquehanna International Group
GSK icon

Susquehanna International Group’s GSK GSK Stock Holding History

Susquehanna International Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.17M Buy
57,448
+48,853
+568% +$2.65M ﹤0.01% 5165
2025
Q4 		$421K Buy
8,595
+2,000
+30% +$93.3K ﹤0.01% 9189
2025
Q3 		$285K Sell
6,595
-60,039
-90% -$2.35M ﹤0.01% 10243
2025
Q2 		$2.56M Buy
66,634
+57,270
+612% +$2.19M ﹤0.01% 5281
2025
Q1 		$363K Sell
9,364
-1,685
-15% -$61.7K ﹤0.01% 9643
2024
Q4 		$374K Sell
11,049
-11,298
-51% -$407K ﹤0.01% 9347
2024
Q3 		$914K Buy
+22,347
New +$914K ﹤0.01% 6991
2024
Q2 		– Sell
-82,766
Closed -$3.48M – 12490
2024
Q1 		$3.55M Buy
82,766
+22,598
+38% +$932K ﹤0.01% 4201
2023
Q4 		$2.23M Sell
60,168
-131,827
-69% -$4.73M ﹤0.01% 5127
2023
Q3 		$6.96M Buy
191,995
+17,046
+10% +$605K ﹤0.01% 3023
2023
Q2 		$6.24M Buy
174,949
+76,746
+78% +$2.75M ﹤0.01% 3172
2023
Q1 		$3.49M Sell
98,203
-152,391
-61% -$5.33M ﹤0.01% 4014
2022
Q4 		$8.81M Buy
250,594
+154,178
+160% +$5.14M ﹤0.01% 2445
2022
Q3 		$2.84M Sell
96,416
-3,658
-4% -$139K ﹤0.01% 4196
2022
Q2 		$5.45M Buy
100,074
+90,360
+930% +$4.99M ﹤0.01% 3046
2022
Q1 		$529K Sell
9,714
-98,342
-91% -$5.34M ﹤0.01% 8832
2021
Q4 		$5.96M Sell
108,056
-277,543
-72% -$14.4M ﹤0.01% 3461
2021
Q3 		$18.4M Buy
385,599
+343,643
+819% +$17.3M ﹤0.01% 2062
2021
Q2 		$2.09M Sell
41,956
-724,796
-95% -$34.8M ﹤0.01% 5821
2021
Q1 		$34.2M Sell
766,752
-87,022
-10% -$3.95M 0.01% 1384
2020
Q4 		$39.3M Buy
853,774
+543,076
+175% +$24.9M 0.01% 1166
2020
Q3 		$14.6M Buy
310,698
+142,828
+85% +$7.16M ﹤0.01% 1791
2020
Q2 		$8.56M Buy
167,870
+69,260
+70% +$3.55M ﹤0.01% 2327
2020
Q1 		$4.67M Buy
+98,610
New +$5.26M ﹤0.01% 2662
2019
Q4 		– Sell
-16,412
Closed -$913K – 10047
2019
Q3 		$876K Sell
16,412
-125,533
-88% -$6.46M ﹤0.01% 5967
2019
Q2 		$7.1M Buy
141,945
+54,604
+63% +$2.74M ﹤0.01% 2282
2019
Q1 		$4.56M Buy
87,341
+33,454
+62% +$1.67M ﹤0.01% 2565
2018
Q4 		$2.57M Buy
53,887
+43,982
+444% +$2.17M ﹤0.01% 3145
2018
Q3 		$497K Buy
+9,905
New +$503K ﹤0.01% 6545
2018
Q2 		– Sell
-731,489
Closed -$36.8M – 9895
2018
Q1 		$35.7M Buy
731,489
+132,292
+22% +$6.16M 0.01% 827
2017
Q4 		$26.6M Buy
599,197
+582,327
+3,452% +$26.9M 0.01% 1054
2017
Q3 		$856K Buy
+16,870
New +$856K ﹤0.01% 5555
2017
Q2 		– Sell
-103,165
Closed -$5.5M – 9412
2017
Q1 		$5.44M Buy
103,165
+14,092
+16% +$715K ﹤0.01% 2272
2016
Q4 		$4.29M Buy
+89,073
New +$4.4M ﹤0.01% 2670
2016
Q3 		– Sell
-56,398
Closed -$3.09M – 8645
2016
Q2 		$3.06M Sell
56,398
-134,257
-70% -$7.07M ﹤0.01% 2901
2016
Q1 		$9.66M Sell
190,655
-363,411
-66% -$18.1M 0.01% 1588
2015
Q4 		$27.9M Sell
554,066
-425,798
-43% -$21.7M 0.01% 904
2015
Q3 		$47.1M Buy
979,864
+549,497
+128% +$28.6M 0.02% 660
2015
Q2 		$22.4M Buy
430,367
+197,553
+85% +$11.1M 0.01% 1210
2015
Q1 		$13.4M Sell
232,814
-792,464
-77% -$45.4M 0.01% 1588
2014
Q4 		$54.8M Buy
1,025,278
+118,013
+13% +$6.6M 0.02% 677
2014
Q3 		$52.1M Buy
907,265
+700,560
+339% +$42.9M 0.02% 725
2014
Q2 		$13.8M Buy
206,705
+99,303
+92% +$6.72M 0.01% 1765
2014
Q1 		$7.17M Sell
107,402
-75,480
-41% -$5.1M ﹤0.01% 2405
2013
Q4 		$12.2M Buy
182,882
+139,588
+322% +$9.05M 0.01% 1821
2013
Q3 		$2.71M Buy
43,294
+726
+2% +$46.7K ﹤0.01% 3628
2013
Q2 		$2.66M Buy
+42,568
New +$2.7M ﹤0.01% 3454

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group's GSK Position: Q1 2026 in Review

Susquehanna International Group increased its GSK (GSK) stake by 568% in Q1 2026, buying an estimated $2.65M and bringing the position to 57,448 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #5165.

Susquehanna International Group first reported a position in GSK in Q2 2013 and has held it in 47 quarters since. The position peaked at $54.8M in Q4 2014. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Susquehanna International Group held 57,448 shares of GSK worth $3.17M as of Q1 2026.
  • Susquehanna International Group bought 48,853 GSK shares in Q1 2026, an estimated $2.65M.
  • GSK made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5165 holding.
  • Susquehanna International Group first reported a position in GSK in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's GSK position peaked at $54.8M in Q4 2014.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.